Vivian Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Vivian Yang has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Gordon Hyeonjin Bae
Department of Dermatology, Stanford University School of Medicine, Redwood City, USA
3 shared publications - Jenna C. Lester
Department of Dermatology, University of California, San Francisco, CA, United States
3 shared publications - Arash Pour Mohammad
Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA
2 shared publications - Carina Shiau
Massachusetts General Hospital 1 Center for Systems Biology Harvard Medical School, Boston, Massachusetts
2 shared publications - Eric Vittinghoff
Department of Epidemiology and Biostatistics, University of California, San Francisco , San Francisco, CA 94158
2 shared publications - Fatuma-Ayaan Rinderknecht
San Francisco School of Medicine, University of California, San Francisco, CA, United States
2 shared publications
Latest Publications
- Open Access
- 15 December 2025
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 8, e78438
Trends in Synchronous Teledermatology Use by Level of Service Among Medicare Beneficiaries From 2017 to 2023: Retrospective Observational Study
This retrospective observational study was conducted to evaluate trends in synchronous teledermatology use across different levels of clinical complexity among Medicare beneficiaries, analyzing data from the Medicare Part B Physician/Supplier Procedure Summary Master Files; we founding that the growing use of teledermatology for complex visits highlights its potential as a long-term approach for improving dermatologic care.
- 15 December 2025
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 8, e78438
Open AccessTrends in Synchronous Teledermatology Use by Level of Service Among Medicare Beneficiaries From 2017 to 2023: Retrospective Observational Study
This retrospective observational study was conducted to evaluate trends in synchronous teledermatology use across different levels of clinical complexity among Medicare beneficiaries, analyzing data from the Medicare Part B Physician/Supplier Procedure Summary Master Files; we founding that the growing use of teledermatology for complex visits highlights its potential as a long-term approach for improving dermatologic care.
- Open Access
- 13 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Medical Students' Perspectives on and Usage of Large Language Models in Medical Education: An Exploratory Survey (Preprint)
BACKGROUND Large Language Models (LLMs) such as ChatGPT are increasingly used by medical students for studying, research, and clinical applications. Despite their growing presence within medical education, concerns persist regarding accuracy, bias, and overreliance. OBJECTIVE To assess how medical students worldwide are using LLMs and to understand their perceptions of and concerns around these tools. METHODS A cross-sectional survey was administered using Qualtrics™ with broad advertising using social media platforms like LinkedIn, Twitter, and Facebook. Responses were summarized using descriptive statistics. RESULTS Among 120 respondents from 13 countries, 88% reported using LLMs, primarily for studying. Common applications included answering questions (67%), summarizing text (51%), and generating practice questions (37%). ChatGPT was the most used LLM (90%). While 84% of medical students reported a positive educational impact, concerns included accuracy (81%), bias (62%), and ethical issues. CONCLUSIONS LLMs are widely used and generally positively perceived by medical students. However, ethical concerns and the need for training in responsible use highlight the importance of educator guidance and further research into educational and clinical outcomes.
- 13 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessMedical Students' Perspectives on and Usage of Large Language Models in Medical Education: An Exploratory Survey (Preprint)
BACKGROUND Large Language Models (LLMs) such as ChatGPT are increasingly used by medical students for studying, research, and clinical applications. Despite their growing presence within medical education, concerns persist regarding accuracy, bias, and overreliance. OBJECTIVE To assess how medical students worldwide are using LLMs and to understand their perceptions of and concerns around these tools. METHODS A cross-sectional survey was administered using Qualtrics™ with broad advertising using social media platforms like LinkedIn, Twitter, and Facebook. Responses were summarized using descriptive statistics. RESULTS Among 120 respondents from 13 countries, 88% reported using LLMs, primarily for studying. Common applications included answering questions (67%), summarizing text (51%), and generating practice questions (37%). ChatGPT was the most used LLM (90%). While 84% of medical students reported a positive educational impact, concerns included accuracy (81%), bias (62%), and ethical issues. CONCLUSIONS LLMs are widely used and generally positively perceived by medical students. However, ethical concerns and the need for training in responsible use highlight the importance of educator guidance and further research into educational and clinical outcomes.
- Open Access
- 2 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Trends in Synchronous Teledermatology Use by Level of Service Among Medicare Beneficiaries from 2017 to 2023: A Retrospective Cohort Study (Preprint)
UNSTRUCTURED This retrospective cohort study was conducted to evaluate the trends of synchronous teledermatology usage across different levels of clinical complexity and found that its increasing use for more complex visits highlights its potential as a long-term approach in dermatologic care.
- 2 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessTrends in Synchronous Teledermatology Use by Level of Service Among Medicare Beneficiaries from 2017 to 2023: A Retrospective Cohort Study (Preprint)
UNSTRUCTURED This retrospective cohort study was conducted to evaluate the trends of synchronous teledermatology usage across different levels of clinical complexity and found that its increasing use for more complex visits highlights its potential as a long-term approach in dermatologic care.
- Open Access
- 21 February 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e50708
Perspectives of Black, Latinx, Indigenous, and Asian Communities on Health Data Use and AI: Cross-Sectional Survey Study
Despite excitement around artificial intelligence (AI)–based tools in health care, there is work to be done before they can be equitably deployed. The absence of diverse patient voices in discussions on AI is a pressing matter, and current studies have been limited in diversity. Our study inquired about the perspectives of racial and ethnic minority patients on the use of their health data in AI, by conducting a cross-sectional survey among 230 participants who were at least 18 years of age and identified as Black, Latinx, Indigenous, or Asian. While familiarity with AI was high, a smaller proportion of participants understood how AI can be used in health care (152/199, 76.4%), and an even smaller proportion understood how AI can be applied to dermatology (133/199, 66.8%). Overall, 69.8% (139/199) of participants agreed that they trusted the health care system to treat their medical information with respect; however, this varied significantly by income (P=.045). Only 64.3% (128/199) of participants felt comfortable with their medical data being used to build AI tools, and 83.4% (166/199) believed they should be compensated if their data are used to develop AI. To our knowledge, this is the first study focused on understanding opinions about health data use for AI among racial and ethnic minority individuals, as similar studies have had limited diversity. It is important to capture the opinions of diverse groups because the inclusion of their data is essential for building equitable AI tools; however, historical harms have made inclusion challenging.
- 21 February 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e50708
Open AccessPerspectives of Black, Latinx, Indigenous, and Asian Communities on Health Data Use and AI: Cross-Sectional Survey Study
Despite excitement around artificial intelligence (AI)–based tools in health care, there is work to be done before they can be equitably deployed. The absence of diverse patient voices in discussions on AI is a pressing matter, and current studies have been limited in diversity. Our study inquired about the perspectives of racial and ethnic minority patients on the use of their health data in AI, by conducting a cross-sectional survey among 230 participants who were at least 18 years of age and identified as Black, Latinx, Indigenous, or Asian. While familiarity with AI was high, a smaller proportion of participants understood how AI can be used in health care (152/199, 76.4%), and an even smaller proportion understood how AI can be applied to dermatology (133/199, 66.8%). Overall, 69.8% (139/199) of participants agreed that they trusted the health care system to treat their medical information with respect; however, this varied significantly by income (P=.045). Only 64.3% (128/199) of participants felt comfortable with their medical data being used to build AI tools, and 83.4% (166/199) believed they should be compensated if their data are used to develop AI. To our knowledge, this is the first study focused on understanding opinions about health data use for AI among racial and ethnic minority individuals, as similar studies have had limited diversity. It is important to capture the opinions of diverse groups because the inclusion of their data is essential for building equitable AI tools; however, historical harms have made inclusion challenging.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Itch
- Vol. 10 (1)
Differences in clinical phenotype between childhood-onset and adult-onset atopic dermatitis: a cross-sectional study
Introduction: Atopic dermatitis (AD) is the most common and burdensome inflammatory skin disease worldwide1. AD is heterogeneous both in its clinical presentation and response to treatment, and it is important to understand how adult-onset AD differs from childhood-onset and whether prevention and treatment strategies should differ. Methods: We performed a cross-sectional study of 18 participants ages 18+ from UCSF dermatology clinics in which we performed clinical assessments and collected patient-reported outcome data using validated surveys. We measured skin barrier function using transepidermal water loss (TEWL) and stratum corneum hydration (SCH) and calculated a frailty score. Results: Adult-onset patients had greater AD severity, worse experience with AD, poorer quality of life, and greater pruritis. In contrast, investigators’ global assessment of AD severity was the same among both groups. Regarding barrier function, TEWL was comparable between both groups, and SCH was higher in childhood-onset AD. We observed several differences in clinical presentation between childhood-onset and adult-onset AD. Adult-onset patients had more severe AD in the trunk and lower extremities, had a higher tendency toward cutaneous infections, were more pruritic, had less facial pallor or erythema, less pityriasis alba, and less Dennie-Morgan infraorbital folds. Discussion: Patient-reported outcomes, including the NRS or more detailed clinical severity scores like EASI and SCORAD, may be more likely to identify differences in severity among adults with AD than a global assessment score. We encourage the use of scales like the NRS and DLQI among the adult AD population, as pruritus and mental health comorbidities are especially common in this population. We recommend the use of frailty scores, especially for older adults, as they can help providers understand the full burden of disease.
- 1 January 2025
- Published by Wolters Kluwer Health in Itch
- Vol. 10 (1)
Open AccessDifferences in clinical phenotype between childhood-onset and adult-onset atopic dermatitis: a cross-sectional study
Introduction: Atopic dermatitis (AD) is the most common and burdensome inflammatory skin disease worldwide1. AD is heterogeneous both in its clinical presentation and response to treatment, and it is important to understand how adult-onset AD differs from childhood-onset and whether prevention and treatment strategies should differ. Methods: We performed a cross-sectional study of 18 participants ages 18+ from UCSF dermatology clinics in which we performed clinical assessments and collected patient-reported outcome data using validated surveys. We measured skin barrier function using transepidermal water loss (TEWL) and stratum corneum hydration (SCH) and calculated a frailty score. Results: Adult-onset patients had greater AD severity, worse experience with AD, poorer quality of life, and greater pruritis. In contrast, investigators’ global assessment of AD severity was the same among both groups. Regarding barrier function, TEWL was comparable between both groups, and SCH was higher in childhood-onset AD. We observed several differences in clinical presentation between childhood-onset and adult-onset AD. Adult-onset patients had more severe AD in the trunk and lower extremities, had a higher tendency toward cutaneous infections, were more pruritic, had less facial pallor or erythema, less pityriasis alba, and less Dennie-Morgan infraorbital folds. Discussion: Patient-reported outcomes, including the NRS or more detailed clinical severity scores like EASI and SCORAD, may be more likely to identify differences in severity among adults with AD than a global assessment score. We encourage the use of scales like the NRS and DLQI among the adult AD population, as pruritus and mental health comorbidities are especially common in this population. We recommend the use of frailty scores, especially for older adults, as they can help providers understand the full burden of disease.
- Open Access
- 13 December 2024
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 7 (1) , e64300
Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx
In the United States, the financial burden of prescription medications has increased exponentially over time. Recently, Mark Cuban founded the Mark Cuban Cost Plus Drug Company (MCCPDC) to help address prescription medication unaffordability. To assess the efficacy of this new pharmaceutical model within dermatology, we conducted an observational cost study of common dermatologic drugs between MCCPDC and GoodRx in the New York, Los Angeles, and Chicago metropolitan areas. The average cost of 15 common dermatology medications was $17.00 through MCCPDC compared to $31.21 through GoodRx (P<0.001). The cost on GoodRx when isolating for the cheapest price available was $21.24 (P=0.026). Our results indicate that MCCPDC has the potential to improve the financial burden of prescription medications within dermatology and should be further explored.
- 13 December 2024
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 7 (1) , e64300
Open AccessImproving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx
In the United States, the financial burden of prescription medications has increased exponentially over time. Recently, Mark Cuban founded the Mark Cuban Cost Plus Drug Company (MCCPDC) to help address prescription medication unaffordability. To assess the efficacy of this new pharmaceutical model within dermatology, we conducted an observational cost study of common dermatologic drugs between MCCPDC and GoodRx in the New York, Los Angeles, and Chicago metropolitan areas. The average cost of 15 common dermatology medications was $17.00 through MCCPDC compared to $31.21 through GoodRx (P<0.001). The cost on GoodRx when isolating for the cheapest price available was $21.24 (P=0.026). Our results indicate that MCCPDC has the potential to improve the financial burden of prescription medications within dermatology and should be further explored.
- Open Access
- 8 July 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Perspectives of Black, Latinx, Indigenous, and Asian Communities on Health Data Use and AI: Cross-Sectional Survey Study (Preprint)
UNSTRUCTURED Despite excitement around artificial intelligence (AI)–based tools in health care, there is work to be done before they can be equitably deployed. The absence of diverse patient voices in discussions on AI is a pressing matter, and current studies have been limited in diversity. Our study inquired about the perspectives of racial and ethnic minority patients on the use of their health data in AI, by conducting a cross-sectional survey among 230 participants who were at least 18 years of age and identified as Black, Latinx, Indigenous, or Asian. While familiarity with AI was high, a smaller proportion of participants understood how AI can be used in health care (152/199, 76.4%), and an even smaller proportion understood how AI can be applied to dermatology (133/199, 66.8%). Overall, 69.8% (139/199) of participants agreed that they trusted the health care system to treat their medical information with respect; however, this varied significantly by income (P=.045). Only 64.3% (128/199) of participants felt comfortable with their medical data being used to build AI tools, and 83.4% (166/199) believed they should be compensated if their data are used to develop AI. To our knowledge, this is the first study focused on understanding opinions about health data use for AI among racial and ethnic minority individuals, as similar studies have had limited diversity. It is important to capture the opinions of diverse groups because the inclusion of their data is essential for building equitable AI tools; however, historical harms have made inclusion challenging.
- 8 July 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPerspectives of Black, Latinx, Indigenous, and Asian Communities on Health Data Use and AI: Cross-Sectional Survey Study (Preprint)
UNSTRUCTURED Despite excitement around artificial intelligence (AI)–based tools in health care, there is work to be done before they can be equitably deployed. The absence of diverse patient voices in discussions on AI is a pressing matter, and current studies have been limited in diversity. Our study inquired about the perspectives of racial and ethnic minority patients on the use of their health data in AI, by conducting a cross-sectional survey among 230 participants who were at least 18 years of age and identified as Black, Latinx, Indigenous, or Asian. While familiarity with AI was high, a smaller proportion of participants understood how AI can be used in health care (152/199, 76.4%), and an even smaller proportion understood how AI can be applied to dermatology (133/199, 66.8%). Overall, 69.8% (139/199) of participants agreed that they trusted the health care system to treat their medical information with respect; however, this varied significantly by income (P=.045). Only 64.3% (128/199) of participants felt comfortable with their medical data being used to build AI tools, and 83.4% (166/199) believed they should be compensated if their data are used to develop AI. To our knowledge, this is the first study focused on understanding opinions about health data use for AI among racial and ethnic minority individuals, as similar studies have had limited diversity. It is important to capture the opinions of diverse groups because the inclusion of their data is essential for building equitable AI tools; however, historical harms have made inclusion challenging.
- 1 November 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (11) , 1503-1509
Acute Consumption of Alcohol and Discrete Atrial Fibrillation Events
Atrial fibrillation (AF) is the most common heart arrhythmia. Long-term alcohol use has been associated with AF. This study examines the relationship between acute ingestion and AF through a case-c... Visual Alcohol and Atrial Fibrillation. Atrial fibrillation (AF) is the most common heart arrhythmia. Long-term alcohol use has been associated with AF. This study examines the relationshi... Background: Patients' self-reports suggest that acute alcohol consumption may trigger a discrete atrial fibrillation (AF) event. Objective: To objectively ascertain whether alcohol consumption heig...
- 1 November 2021
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (11) , 1503-1509
Acute Consumption of Alcohol and Discrete Atrial Fibrillation Events
Atrial fibrillation (AF) is the most common heart arrhythmia. Long-term alcohol use has been associated with AF. This study examines the relationship between acute ingestion and AF through a case-c... Visual Alcohol and Atrial Fibrillation. Atrial fibrillation (AF) is the most common heart arrhythmia. Long-term alcohol use has been associated with AF. This study examines the relationshi... Background: Patients' self-reports suggest that acute alcohol consumption may trigger a discrete atrial fibrillation (AF) event. Objective: To objectively ascertain whether alcohol consumption heig...
- Open Access
Predictors of Incident Viral Symptoms Ascertained in the Era of Covid-19
Background: In the absence of universal testing, effective therapies, or vaccines, identifying risk factors for viral infection, particularly readily modifiable exposures and behaviors, is required to identify effective strategies against viral infection and transmission. Methods: We conducted a world-wide mobile application-based prospective cohort study available to English speaking adults with a smartphone. We collected self-reported characteristics, exposures, and behaviors, as well as smartphone-based geolocation data. Our main outcome was incident symptoms of viral infection, defined as fevers and chills plus one other symptom previously shown to occur with SARS-CoV-2 infection, determined by daily surveys. Findings: Among 14, 335 participants residing in all 50 US states and 93 different countries followed for a median 21 days (IQR 10-26 days), 424 (3%) developed incident viral symptoms. In pooled multivariable logistic regression models, female biological sex (odds ration [OR] 1.75, 95% CI 1.39-2.20, p<0.001), anemia (OR 1.45, 95% CI 1.16-1.81, p=0.001), hypertension (OR 1.35, 95% CI 1.08-1.68, p=0.007), cigarette smoking in the last 30 days (OR 1.86, 95% CI 1.35-2.55, p<0.001), any viral symptoms among household members 6-12 days prior (OR 2.06, 95% CI 1.67-2.55, p<0.001), and the maximum number of individuals the participant interacted with within 6 feet in the past 6-12 days (OR 1.15, 95% CI 1.06-1.25, p<0.001) were each associated with a higher risk of developing viral symptoms. Conversely, a higher subjective social status (OR 0.87, 95% CI 0.83-0.93, p<0.001), at least weekly exercise (OR 0.57, 95% CI 0.47-0.70, p<0.001), and sanitizing one’s phone (OR 0.79, 95% CI 0.63-0.99, p=0.037) were each associated with a lower risk of developing viral symptoms. Interpretation: While several immutable characteristics were associated with the risk of developing viral symptoms, multiple immediately modifiable exposures and habits that influence risk were also observed, potentially identifying readily accessible strategies to mitigate risk in the Covid-19 era. Funding: This study was funded by IU2CEB021881-01 and 3U2CEB021881-05S1 from the NIH/ NIBIB to Drs. Marcus, Olgin, and Pletcher. Research in context: Evidence before this study: Predictors of incident viral infection have been determined largely from cross-sectional studies prone to recall bias among individuals representing geographically constrained regions, and most were conducted before the era of the current Covid-19 pandemic. Added value of this study: We conducted a world-wide, mobile application-based, longitudinal cohort study utilizing time-updated predictors and outcomes, providing novel and current information regarding risk-factors for incident viral symptoms based on real-time information in the era of Covid-19. Implications of all the available evidence: These data suggest that certain immutable characteristics influence the risk for incident viral symptoms, while smoking cessation, physical distancing to avoid contact with individuals outside the household, regular exercise, and sanitizing one’s phone may each help mitigate the risk of viral infection.
Open AccessPredictors of Incident Viral Symptoms Ascertained in the Era of Covid-19
Background: In the absence of universal testing, effective therapies, or vaccines, identifying risk factors for viral infection, particularly readily modifiable exposures and behaviors, is required to identify effective strategies against viral infection and transmission. Methods: We conducted a world-wide mobile application-based prospective cohort study available to English speaking adults with a smartphone. We collected self-reported characteristics, exposures, and behaviors, as well as smartphone-based geolocation data. Our main outcome was incident symptoms of viral infection, defined as fevers and chills plus one other symptom previously shown to occur with SARS-CoV-2 infection, determined by daily surveys. Findings: Among 14, 335 participants residing in all 50 US states and 93 different countries followed for a median 21 days (IQR 10-26 days), 424 (3%) developed incident viral symptoms. In pooled multivariable logistic regression models, female biological sex (odds ration [OR] 1.75, 95% CI 1.39-2.20, p<0.001), anemia (OR 1.45, 95% CI 1.16-1.81, p=0.001), hypertension (OR 1.35, 95% CI 1.08-1.68, p=0.007), cigarette smoking in the last 30 days (OR 1.86, 95% CI 1.35-2.55, p<0.001), any viral symptoms among household members 6-12 days prior (OR 2.06, 95% CI 1.67-2.55, p<0.001), and the maximum number of individuals the participant interacted with within 6 feet in the past 6-12 days (OR 1.15, 95% CI 1.06-1.25, p<0.001) were each associated with a higher risk of developing viral symptoms. Conversely, a higher subjective social status (OR 0.87, 95% CI 0.83-0.93, p<0.001), at least weekly exercise (OR 0.57, 95% CI 0.47-0.70, p<0.001), and sanitizing one’s phone (OR 0.79, 95% CI 0.63-0.99, p=0.037) were each associated with a lower risk of developing viral symptoms. Interpretation: While several immutable characteristics were associated with the risk of developing viral symptoms, multiple immediately modifiable exposures and habits that influence risk were also observed, potentially identifying readily accessible strategies to mitigate risk in the Covid-19 era. Funding: This study was funded by IU2CEB021881-01 and 3U2CEB021881-05S1 from the NIH/ NIBIB to Drs. Marcus, Olgin, and Pletcher. Research in context: Evidence before this study: Predictors of incident viral infection have been determined largely from cross-sectional studies prone to recall bias among individuals representing geographically constrained regions, and most were conducted before the era of the current Covid-19 pandemic. Added value of this study: We conducted a world-wide, mobile application-based, longitudinal cohort study utilizing time-updated predictors and outcomes, providing novel and current information regarding risk-factors for incident viral symptoms based on real-time information in the era of Covid-19. Implications of all the available evidence: These data suggest that certain immutable characteristics influence the risk for incident viral symptoms, while smoking cessation, physical distancing to avoid contact with individuals outside the household, regular exercise, and sanitizing one’s phone may each help mitigate the risk of viral infection.